6 completed, 2 recruiting, 1 terminated. 4 Not applicable, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Stage II Ovarian Cancer: new trials by email Literature Review of Stage II Ovarian Cancer trials Research Report on Stage II Ovarian Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) Mind-body resilience training, Music therapy, Propranolol - Ovarian Cancer, Ovarian Carcinoma | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 35 | 2022-06-17 | 2026-07-01 |
| Ask Questions (ASQ):Implementation of a Communication Intervention Behavioral Intervention - Stage II Breast Cancer, Stage III Breast Cancer | Not applicable | Completed | Barbara Ann Karmanos Cancer Institute | 81 | 2021-08-25 | 2023-08-16 |
| Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer Uterine lavage, or a wash of the womb, Blood sample, Pap smear - Ovarian Neoplasms, Ovarian Epithelial Carcinoma | Recruiting | Massachusetts General Hospital | 250 | 2020-04-13 | 2025-09-16 | |
| Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer Diagnostic Microscopy, Fluorescein Sodium Injection, Laboratory Biomarker Analysis - Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | Early Phase 1 | Completed | Roswell Park Cancer Institute | 19 | 2017-11-06 | 2021-10-06 |
| Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors Informational Intervention - Stage I Breast Cancer, Stage I Cervical Cancer | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 40 | 2015-08-01 | 2025-04-29 |
| Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer Adjuvant Therapy, Aprepitant, Carboplatin - Nausea and Vomiting, Ovarian Brenner Tumor | Not applicable | Terminated | Gynecologic Oncology Group | 4 | 2011-06-01 | 2018-05-22 |
| Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Cognitive Assessment, Quality-of-Life Assessment - Cognitive Side Effects of Cancer Therapy, Malignant Ovarian Epithelial Tumor | Completed | Gynecologic Oncology Group | 247 | 2010-04-01 | 2018-04-12 | |
| Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Paclitaxel, Cisplatin - Chemotherapeutic Agent Toxicity, Endometrial Adenocarcinoma | Phase 1 | Completed | Gynecologic Oncology Group | 23 | 2009-02-01 | 2014-12-31 |
| Collecting Tumor Samples From Patients With Gynecological Tumors Laboratory Biomarker Analysis - Borderline Ovarian Clear Cell Tumor, Borderline Ovarian Serous Tumor | Completed | Gynecologic Oncology Group | 275 | 1992-06-01 | 2016-10-28 |
Ovarian Neoplasms (9) · Fallopian Tube Neoplasms (7) · Brenner Tumor (4) · Uterine Cervical Neoplasms (3) · Breast Neoplasms (2) · Carcinoma, Ovarian Epithelial (2) · Colorectal Neoplasms (1) · Dysgerminoma (1) · Gestational Trophoblastic Disease (1) · Kidney Neoplasms (1) · Lung Neoplasms (1) · Melanoma (1) · Mesothelioma, Malignant (1) · Nausea (1) · Neoplasms (1)
Adnexal Diseases (9) · Endocrine Gland Neoplasms (9) · Endocrine System Diseases (9) · Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Genital Diseases (9) · Genital Diseases, Female (9) · Genital Neoplasms, Female (9) · Gonadal Disorders (9) · Neoplasms by Site (9) · Urogenital Diseases (9) · Urogenital Neoplasms (9) · Neoplasms (8) · Ovarian Diseases (8) · Fallopian Tube Diseases (7)
Cisplatin (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Aprepitant (1) · Behavior Therapy (1) · Blood Specimen Collection (1) · Calcium Dobesilate (1) · Carboplatin (1) · Chemotherapy, Adjuvant (1) · Dexamethasone (1) · Etodolac (1) · Fluorescein (1) · Fluoresceins (1) · Granisetron (1) · Mental Status and Dementia Tests (1) · Music Therapy (1)
Gynecologic Oncology Group (4) · Barbara Ann Karmanos Cancer Institute (1) · Massachusetts General Hospital (1) · Memorial Sloan Kettering Cancer Center (1) · Roswell Park Cancer Institute (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
United States (9)
Andrea Barsevick, PhD (1) · Christos Patriotis, PhD (1) · Don Dizon (1) · Emese Zsiros, MD (1) · Lisa Hess (1) · Michael Cibull (1) · Steven Plaxe (1) · Susan Eggly, PhD (1)
U10CA101165 (2), U01CA152990 (1), U10CA027469 (1), U10CA180868 (1), U2CCA271871 (1)